Bank of America’s Senti Biosciences Holdings SNTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SNTI
NMC
NCM
MVM
XT
HF
Bank of America's SNTI Position: Q1 2026 in Review
Bank of America sold out of Senti Biosciences Holdings (SNTI) in Q1 2026, closing a stake of 75 shares — an estimated $78 sold.
Bank of America first reported a position in SNTI in Q2 2021 and held it in 15 quarters. The position peaked at $31K in Q3 2022. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.
- Bank of America reported no remaining Senti Biosciences Holdings position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 75 Senti Biosciences Holdings shares in Q1 2026, an estimated $78.
- Bank of America first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 15 quarters.
- Bank of America's Senti Biosciences Holdings position peaked at $31K in Q3 2022.
- 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.